HomeAI · summaries
Storia in 2 fonti
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Surat-based Anupam Rasayan India to acquire upto 74.2 per cent in Bliss GVS Pharma
Anupam Rasayan India to acquire up to 74.2% stake in Bliss GVS Pharma, enhancing its global pharmaceutical presence.
- ·
economictimes.indiatimes.com
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This…
- ·
Buzzing stocks today: Anupam Rasayan, Bliss GVS, Oil India, NBCC, RVNL, Lupin, Aurobindo Pharma, Goodluck, PNC Infra, Sterlite Tech, CBI…
Explore major stock developments involving Anupam Rasayan, Bliss GVS, Oil India, and more in this concise market overview.